Maplight Therapeuticsincis A Clinical Stage Biopharmaceutical Company Based In Burlingtonmassachusettsfounded In 2018The Company Focuses On Developing Targeted Treatments For Central Nervous Systemcnsdisorderstheir Mission Is To Enhance The Lives Of Individuals With Challenging Brain Disorders Through Circuit Specific Therapies That Offer A More Effective Approach Than Traditional Treatments The Company Employs Advanced Technologies Such As Optogeneticsstarmapand Transcriptomics To Discover And Develop Novel Therapeuticsmaplight S Clinical Pipeline Includes Compounds For Schizophrenia And Alzheimer S Disease Psychosiswhile Their Preclinical Efforts Explore Treatments For Parkinson S Diseasehyperactivityimpulsivityand Autism Spectrum Disorderin October 2023Maplight Secured $225 Million In Series C Funding To Support The Advancement Of Their Innovative Therapieshighlighting Their Potential In Addressing Significant Cns Disorders
No conferences found for this company.
| Company Name | Maplight Therapeutics Inc |
| Country |
United States
|
| Address | 501 2nd Street San Francisco California 94107 United States |
| Telephone | Login to View |
| Login to View |
